Drug-eluting stents (DES) were developed to overcome in-stent restenosis (ISR), which has
long been considered the main complication limiting the long-term efficacy of coronary …

Restenosis is a complex disease for which the pathophysiological mechanisms have not yet
been fully elucidated, but are thought to include inflammation, proliferation, and matrix …

Diabetes mellitus (DM) is a strong risk factor for the development of cardiovascular diseases
such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease …

BACKGROUND: High-intensity interval training has been shown to be superior to moderate
continuous exercise training in improving exercise capacity and endothelial function in …

Percutaneous coronary intervention (PCI) has evolved significantly over the past four
decades. Since its inception, in-stent restenosis (ISR)—the progressive reduction in vessel …

Inflammation plays a crucial role in the pathogenesis of in-stent restenosis (ISR). Neutrophil-
to-lymphocyte ratio (NLR) provides a simple method for assessment of inflammatory status …

Coping with cardiovascular diseases (CVD), which are of the main causes of death
worldwide, has influenced investigation of high sensitivity CRP (hsCRP) and its role in …

The main adverse reactions to coronary stents are in-stent restenosis (ISR) and stent
thrombosis. Along with procedural factors, individual susceptibility to these events plays an …

This paper presents the proof of concept for a new solution to the problem of recomposing
missing information at the SCADA of energy/distribution management systems (EMS/DMS) …

Introduction Stent restenosis remains a clinical challenge for patients with ischemic heart
disease, since it is associated with repeated coronary interventions as well as higher …